Zydus Lifesciences Ltd.

BSE: 532321 | NSE: ZYDUSLIFE
Mid Cap | Pharmaceuticals & Drugs
942.55
3.35 (0.36%)
< Home < Back

Cadila Healthcare’s Q1 consolidated net declines 15%

Date: 06-08-2012

Cadila Healthcare has reported results for first quarter ended June 30, 2012.

On standalone basis, the company has reported a fall of 13.23% in its net profit at Rs 132.70 crore for the quarter, as compared to Rs 152.93 crore for the same quarter in the previous year. However, total income of the company has increased by 4% to Rs 822.11 crore for the quarter under review as compared to Rs 790.52 crore for the quarter ended June 30, 2011.

On consolidated basis, the company has reported a fall of 15.24% in its net profit at Rs 194.79 crore for the quarter, as compared to Rs 229.82 crore for the same quarter in the previous year. However, total income of the company has increased by 28.11% to Rs 1603.93 crore for the quarter under review as compared to Rs 1252.00 crore for the quarter ended June 30, 2011.